EW
55
5
SCHW
40
3
TRV
34
4
HCP
54
2
ABBV
40
5
SLB
41
2
AZO
46
3
HAL
40
11
ADT
12
2
WAT
55
11
PNW
55
3
EFX
43
3
ITW
45
2
BEN
36
4
CTAS
36
8
IVZ
42
13
HSIC
42
2
HSY
32
3
MMM
35
3
INTU
54
2
EW
55
5
SCHW
40
3
TRV
34
4
HCP
54
2
ABBV
40
5
SLB
41
2
AZO
46
3
HAL
40
11
ADT
12
2
WAT
55
11
PNW
55
3
EFX
43
3
ITW
45
2
BEN
36
4
CTAS
36
8
IVZ
42
13
HSIC
42
2
HSY
32
3
MMM
35
3
INTU
54
2
Financhill
Back

ImmunityBio 10K Form

Sell
29

IBRX
ImmunityBio

Last Price:
$2.62
Seasonality Move:
3.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IBRX News And Ratings

See the #1 stock for the next 7 days that we like better than IBRX

IBRX Financial Statistics

Sales & Book Value

Annual Sales: $622K
Cash Flow: $-101.6M
Price / Cash Flow: 0
Annual Sales: $-1.07
Price / Book: 0

Profitability

EPS (TTM): -0.90000
Net Income (TTM): $-587.8M
Gross Margin: --
Return on Equity: 0%
Return on Assets: -136.92%

ImmunityBio Earnings Forecast

Key ImmunityBio Financial Ratios

  • The Research & Development expenses have been 37,357.88% of Revenue.
  • The Interest Expense is -22.15% of Operating Income.
  • The Net Earning history of IBRX is -93,761.41% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 0 years.

ImmunityBio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IBRX
Website: immunitybio.com

Debt

Debt-to-Equity Ratio: -0.94
Current Ratio: 2.68
Quick Ratio: 2.22

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IBRX Technical Analysis vs Fundamental Analysis

Sell
29
ImmunityBio (IBRX) is a Sell

Is ImmunityBio a Buy or a Sell?

  • ImmunityBio stock is rated a Sell
    The current ImmunityBio [IBRX] share price is $2.62. The Score for IBRX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.